Agile Therapeutics (AGRX) director Barbari received 24,510 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Sharon Barbari (director at Agile Therapeutics Inc., AGRX) reported that they received 24,510 shares on Jun 8, 2021. After these transactions the filing shows 51,296 shares held directly.
- Reporting person
- Barbari Sharon
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 8, 2021 | Grant or award (A) | Common Stock1 | +24,510 | - | - | 51,296 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 8, 2021 | Grant or award (A) | Employee Stock Option (Right to Buy)On 29,905 Common Stock2 | +29,905 | - | - | 29,905 direct |
Holdings before and after
- Common Stock: 26,786 to 51,296 direct
- Employee Stock Option (Right to Buy): 0 to 29,905 direct
Footnotes from the filing
- 1. These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.
- 2. The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Barbari report in this AGRX Form 4?
Sharon Barbari (director at Agile Therapeutics Inc., AGRX) reported that they received 24,510 shares on Jun 8, 2021. After these transactions the filing shows 51,296 shares held directly.
How many AGRX shares does Barbari hold after this filing?
The filing shows 51,296 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for AGRX
Earlier insider filings at AGRX
- Jun 10, 2021SEC Form 4: Shetty Ajit was granted 24,510 units of Common Stock, increasing direct ownership by 64% to 62,852 units
- Jun 10, 2021SEC Form 4: Tursi James Patrick was granted 24,510 units of Common Stock, increasing direct ownership by 78% to 55,852 units
- May 12, 2021SEC Form 4: Reilly Dennis bought $27,000 worth of Common Stock (20,000 units at $1.35), increasing direct ownership by 13% to 176,306 units
- Apr 6, 2021SEC Form 4 filed by Llc Advisors Perceptive
- Mar 30, 2021SEC Form 4: Jason Butch bought $20,073 worth of Common Stock (10,000 units at $2.01), increasing direct ownership by 100% to 20,000 units
Quantisnow market dataNASDAQ
AGRX
Agile Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for AGRX
Full AGRX profile on Quantisnow Follow AGRX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time